| Name | Title | Contact Details |
|---|
Neos Therapeutics is focused on developing, manufacturing and commercializing branded products utilizing our proprietary extended-release drug delivery technology platform, which serves as the basis for our three product candidates being investigated for the treatment of attention deficit hyperactivity disorder (ADHD). Our ADHD product candidates include the following formulations; oral disintegrating tablets (ODT) and liquid suspension. Drug Delivery Platform: Our proprietary extended-release drug delivery platform has enabled us to create new patient- and caregiver-friendly dosage forms of methylphenidate and amphetamine. Formulations: In 2014 alone, 63.1 million prescriptions for medications with ADHD labeling, and principally in extended-release formulations, were written in the United States. The majority of currently available dosage forms for ADHD are tablets and capsules. The two lead Neos Therapeutics product candidates provide a plasma concentration-time profile that is consistent with once daily dosing in an orally disintegrating tablet that disintegrates in the mouth without water. Our goal is to be a leading pharmaceutical company focused on the development, manufacture and commercialization of branded pharmaceutical products that utilize our proprietary extended-release drug delivery technology platform. Neos Therapeutics is a growing, dynamic company that can provide employees with the opportunities and challenges they need to enjoy a rewarding career and make a difference in the lives of others. Our success depends on a motivated team of people collaborating to create quality healthcare products. This requires employees with exceptional leadership skills, flexibility, technical expertise and a commitment to excellence. We offer competitive compensation packages to full-time employees. We seek to attract the right people and provide incentives and career development that can turn employment into opportunity.
Hanwha SolarOne Co is a vertically-integrated manufacturer of silicon ingots, wafers, PV cells and modules.
Ener-Core, Inc. (“Ener-Core”) designs and manufactures innovative systems for producing continuous energy from a broad range of sources, including previously unusable ultra-low quality gas. The Ener-Core Gradual Oxidizer, our patented oxidation technology, enables the conversion of these gases into useful heat and power with the lowest known associated emissions. With the Ener-Core Gradual Oxidizer matched to gas turbines, Ener-Core offers systems with fuel flexibility and pollution control for power generation. The Gradual Oxidizer can also be customized for integration with larger existing power generation systems to offer unparalleled pollution control and achieve zero emissions. Ener-Core has developed the 250kW Ener-Core Powerstation FP250 (“FP250”), and its larger counterpart, the 2MW Ener-Core Powerstation KG2-3G/GO, to transform methane gas, especially “ultra-low Btu gas” from landfills, coal mines, oil fields and other low quality methane sources into continuous clean electricity with near-zero emissions. The Powerstations are specifically engineered for fuel flexibility and modularity, so that these low-Btu gas sources can be used as an energy resource instead of wasted through venting and/or flaring. With dedication, deep expertise, and broad energy experience, Ener-Core serves several markets globally, including oil fields, biogas, coal mines, natural gas, emissions control, and utility power generation.
Orbit Manufacturing Co is a Perkasie, PA-based company in the Manufacturing sector.
T.J. Harkins Basic Commodity Brokers is a Bolingbrook, IL-based company in the Manufacturing sector.